SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is currently drawing intense investor interest as it navigates a volatile transition from a pure-play Bitcoin miner to an AI and high-performance computing infrastructure provider. While the stock's massive short interest and aggressive capital expenditure strategy have fueled sharp disagreements among market participants regarding dilution risks and execution, the community remains hyper-focused on the company's potential to land a major hyperscale data center deal that could act as a catalyst for a sustained re-rating.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a major focus of community debate, with enthusiasts pushing for price catalysts and supply burns while skeptics share recurring fraud allegations and criticisms regarding the token's long-term utility. Despite the polarized sentiment, active traders are closely monitoring chart patterns for potential breakouts as they compare its performance against other meme coins.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA token is trending as investors debate whether it represents a legitimate political engagement or yet another high-profile grift within the Trump-related crypto ecosystem. The community remains deeply polarized, with critics pointing to massive losses and historical pump-and-dump concerns, while a smaller cohort continues to speculate on future utility and market recovery.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant upward momentum driven by heavy institutional buying and intense speculative interest regarding a potential short squeeze, with investors closely watching the upcoming earnings report. The community is actively debating the stock's squeeze potential while highlighting the company's expanding enterprise voice AI partnerships as a major long-term catalyst.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following the announcement of an End-of-Phase 2 meeting with the FDA, which cleared a registration path for its lead program, CAD-1005, to treat heparin-induced thrombocytopenia. Community discussion is split between optimism regarding the potential for this first-in-class 12-LOX inhibitor and skepticism driven by concerns over future capital raises and persistent bot-driven spam.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost is trending as traders debate its potential as a privacy-focused utility play on the Solana ecosystem versus concerns over project legitimacy and volatility. Community members are actively discussing upcoming infrastructure launches while navigating significant price swings and polarized opinions regarding its long-term viability.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae shares are surging following high-profile endorsements from prominent investors Bill Ackman and Michael Burry, who labeled the stock "stupidly cheap" and highlighted potential long-term upside from privatization. The community is buzzing with speculation about a possible upcoming exit from conservatorship, leading to intense trading activity and debate over whether the price action is a sustainable breakout or a temporary pump-and-dump scheme.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing intense community debate as investors speculate on the upcoming Goliath mainnet launch, with bulls pointing toward institutional adoption potential while bears remain skeptical of the project's long-term utility and historical price action. The conversation is currently dominated by conflicting perspectives on whether the coin is positioned for a significant technical breakout or if the current momentum is merely another recurring pump-and-dump cycle.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently facing intense community debate as holders grapple with prolonged price stagnation and frustration over a lack of transparent project updates. While some investors view the current low valuation as a strategic accumulation opportunity ahead of future IoT-related catalysts, critics remain skeptical, pointing to the emergence of related projects like Janction as a potential distraction from Jasmy's long-term utility.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is seeing renewed community interest fueled by rising trading volume and speculation regarding upcoming burn mechanisms, leading to bullish sentiment despite the token's historical volatility. Holders are actively discussing potential price catalysts while debating the sustainability of the recent upward movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Restaurant Brands International Inc. (QSR) were in the spotlight on Tuesday after the company said its subsidiary bought a 100% stake in Burger King China for about $158 million in an all-cash transaction.RBI acquired the stake from TFI Asia Holdings BV and Pangaea Two Acquisition Holdings XXIII Ltd, according to a statement.With the deal, RBI plans to engage advisors to assist the company in identifying a new local partner to inject primary capital into the business and become the controlling shareholder.RBI’s long-term strategy has been to partner with “experienced local operators” while maintaining a primarily franchised business, the company said in a statement.Sentiment on Stocktwits turned ‘bullish’ from ‘extremely bullish’ a week ago. Message volumes remained in the ‘high’ zone.<figure class="image"><img style="aspect-ratio:1304/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_19_at_6_52_56_AM_72430c23e0.png" alt="Screenshot 2025-02-19 at 6.52.56 AM.png" width="1304" height="320"><figcaption>QSR sentiment meter and message volumes on Feb 18</figcaption></figure>Under TFI’s watch Burger King has grown from about 60 restaurants in 2012 to 1,500, with plans to continue its expansion into Turkey, according to the statement.According to <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/retail-consumer/restaurant-brands-takes-full-control-burger-king-china-2025-02-18/">Reuters</a>, the company has been refining its China strategy for Burger King as it grapples with weakening demand in its second-largest market, amid pressured consumer spending and intense competition.Restaurant Brands has nearly $45 billion in annual system-wide sales and over 32,000 restaurants in more than 120 countries and territories. Its brands include Tim Hortons, Burger King, Popeyes, and Firehouse Subs.<a href="https://stocktwits.com/symbol/QSR">Restaurant Brands stock</a> is down more than 1% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Restaurant Brands Seizes Full Control Of Burger King China In $158M Deal: Retail Stays Bullish

The company said its long-term strategy has been to partner with “experienced local operators” while maintaining a primarily franchised business

Equity

Biogen Inc. shares climbed 1.7% on Monday afternoon, reaching a nearly two-week high, as positive regulatory news countered fallout from a rejected acquisition proposal.Sage Therapeutics announced its board had unanimously rejected Biogen's unsolicited Jan. 10&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sage-stock-soars-on-biogen-bid/chGN0nXRNV">offer</a> to acquire all outstanding Sage shares for $7.22 per share.&nbsp;The small-cap biotech firm called the proposal "significantly undervaluing" the company and added that it was not in the best interest of its shareholders.Sage's board also revealed plans to explore strategic alternatives, cautioning that a transaction is not guaranteed.&nbsp;Meanwhile, Sage reaffirmed its commitment to establishing Zurzuvae as the standard treatment for postpartum depression.&nbsp;Biogen, which co-markets Zurzuvae, had argued that full ownership would aid its rollout but expressed little interest in Sage's broader pipeline when it placed its bid.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BIIB_sentiment_and_message_volume_Jan_27_d1b89b799f.png" alt="BIIB sentiment and message volume Jan 27.png" width="1318" height="324"><figcaption>BIIB sentiment and message volume Jan 27 as of 1:20 pm ET | source: Stocktwits</figcaption></figure>Following the rejection, retail sentiment for Biogen turned 'bearish' on Stocktwits, with increased message volume reflecting investor concerns about the deal's implications.<stembedurl>https://stocktwits.com/Gito/message/601644664</stembedurl><stembedurl>https://stocktwits.com/Scanners_Free/message/601610361</stembedurl>However, Biogen received a significant boost as the FDA on Sunday approved a supplemental biologics license application for Leqembi, developed in collaboration with Eisai Co. Ltd.&nbsp;The new label allows for once-every-four-weeks intravenous maintenance dosing following an 18-month initiation phase of biweekly treatments.Leqembi, used to treat early-stage Alzheimer's disease, addresses patients with mild cognitive impairment or mild dementia.&nbsp;The updated dosing regimen is expected to improve patient compliance while enhancing convenience.However, Biogen's challenges remain stark; the stock has lost nearly 40% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the logo of Biogen is seen on a smartphone with the FDA logo in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)  

Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail

The small-cap biotech firm called the proposal "significantly undervaluing" the company and added that it was not in the best interest of its shareholders.

Current Price	$74.44
Prev Close	$74.59
Open	$74.95
Dividend Yield	N/A
50-Day Moving Average	$73.38
Beta	N/A
Avg. Volume	17,688.93
PE Ratio	N/A

52-Week High	$75.54
52-Week Low	$64.77
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

QLV
FlexShares Trust - FlexShares US Quality Low Volatility Index Fund

Feed

News

Sentiment

Fundamentals

Info

Latest QLV News

QLVFlexShares Trust - FlexShares US Quality Low Volatility Index Fund